The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types

<b>Background:</b> Anti-PAR 1 (protease-activated receptor 1) and anti-ACE 2 (angiotensin 2-converting enzyme 2) antibodies are a kind of non-HLA (human leukocyte antigens) antibodies postulated to be of significance in autoimmunological diseases and organ transplantation. <b>Methods:</b> We assessed anti-PAR 1 and anti-ACE 2 antibody levels in patients with membranous nephropathy <i>n</i>= 18, focal and segmental glomerulosclerosis (FSGS) <i>n</i> = 25, lupus nephritis (LN) <i>n</i> = 17, IgA nephropathy <i>n</i> = 14, mesangial proliferative (non-IgA) glomerulonephritis <i>n</i> = 6, c-ANCA (cytoplasmic anti-neutrophil cytoplasmic antibodies) vasculitis <i>n</i> = 40, p (perinuclear)-ANCA vasculitis <i>n</i> = 16, and compared them with a healthy control group <i>n</i> = 22. Next, we observed the clinical course of the patients (creatinine, total protein, and albumin) up to 2 years and correlated the results with the level of antibodies. <b>Results:</b> The anti-PAR 1 antibody level was lower in membranous nephropathy and FSGS compared to the control group. Anti-PAR 1 antibody levels were higher in secondary compared to primary glomerulonephritis. Both anti-PAR 1 and anti-ACE 2 antibody levels correlated positively (in focal and segmental glomerulosclerosis) or negatively (in lupus nephritis) with total protein and albumin at different time points of observation. Anti-PAR 1 and anti-ACE 2 antibody levels correlated also with creatinine level at one time point of observation in IgA nephropathy. Anti-PAR 1 and anti-ACE 2 antibodies correlated with each other in membranous nephropathy, FSGS, and p- and c-ANCA vasculitis (<i>p</i> < 0.05). <b>Conclusions:</b> The anti-PAR 1 antibody level was lower in membranous nephropathy and focal and segmental glomerulosclerosis compared to the control group. Anti-PAR 1 antibody levels tend to be higher in secondary compared to primary glomerulonephritis.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-05-04
DOI
https://doi.org/10.3390/jcm14093178
Citations
2
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
2.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types

Kai Schulze‐Forster, Jakub Wronowicz, Mirosław Banasik, Tomasz Gołębiowski et al.
2 citations
Journal of Clinical Medicine
Renal Diseases and Glomerulopathies
2.86
article

The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types

Kai Schulze‐Forster, Jakub Wronowicz, Mirosław Banasik, Tomasz Gołębiowski, Karolina Marek-Bukowiec, Marcelina Żabińska, Krzysztof Kujawa, Maciej Szymczak, Łucja Janek, Harald Heidecke
article en
2 citations

Abstract

<b>Background:</b> Anti-PAR 1 (protease-activated receptor 1) and anti-ACE 2 (angiotensin 2-converting enzyme 2) antibodies are a kind of non-HLA (human leukocyte antigens) antibodies postulated to be of significance in autoimmunological diseases and organ transplantation. <b>Methods:</b> We assessed anti-PAR 1 and anti-ACE 2 antibody levels in patients with membranous nephropathy <i>n</i>= 18, focal and segmental glomerulosclerosis (FSGS) <i>n</i> = 25, lupus nephritis (LN) <i>n</i> = 17, IgA nephropathy <i>n</i> = 14, mesangial proliferative (non-IgA) glomerulonephritis <i>n</i> = 6, c-ANCA (cytoplasmic anti-neutrophil cytoplasmic antibodies) vasculitis <i>n</i> = 40, p (perinuclear)-ANCA vasculitis <i>n</i> = 16, and compared them with a healthy control group <i>n</i> = 22. Next, we observed the clinical course of the patients (creatinine, total protein, and albumin) up to 2 years and correlated the results with the level of antibodies. <b>Results:</b> The anti-PAR 1 antibody level was lower in membranous nephropathy and FSGS compared to the control group. Anti-PAR 1 antibody levels were higher in secondary compared to primary glomerulonephritis. Both anti-PAR 1 and anti-ACE 2 antibody levels correlated positively (in focal and segmental glomerulosclerosis) or negatively (in lupus nephritis) with total protein and albumin at different time points of observation. Anti-PAR 1 and anti-ACE 2 antibody levels correlated also with creatinine level at one time point of observation in IgA nephropathy. Anti-PAR 1 and anti-ACE 2 antibodies correlated with each other in membranous nephropathy, FSGS, and p- and c-ANCA vasculitis (<i>p</i> < 0.05). <b>Conclusions:</b> The anti-PAR 1 antibody level was lower in membranous nephropathy and focal and segmental glomerulosclerosis compared to the control group. Anti-PAR 1 antibody levels tend to be higher in secondary compared to primary glomerulonephritis.

Journal of Clinical MedicineVol. 14(9)
Wrocław University of Science and Technology (PL), Wroclaw Medical University (PL), AGH University of Krakow (PL)
Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu
Good health and well-being
Openalex Percentile: Top 10%
Renal Diseases and Glomerulopathies
2.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.